CT-Based Radiomics Can Predict the Efficacy of Anlotinib in Advanced Non-Small-Cell Lung Cancer

Figure 4

DCA of the training set and the internal and external validation set of four models based on the RAD score only and a combination of radiomics and clinical features, respectively. (a) NCE radiomic only model; (b) CE radiomic only model; (c) NCE radiomic-combined model; (d) CE radiomic-combined model.

(a)

(b)

(c)

(d)